These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19710589)

  • 1. Neonatal vaccination: a once in a lifetime opportunity.
    Demirjian A; Levy O
    Pediatr Infect Dis J; 2009 Sep; 28(9):833-5. PubMed ID: 19710589
    [No Abstract]   [Full Text] [Related]  

  • 2. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
    Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
    An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Laws HJ; Calaminus G; Göbel U
    Cancer; 2005 Apr; 103(8):1759; author reply 1760. PubMed ID: 15717299
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Fioredda F; Giacchino M; Castagnola E
    Cancer; 2005 Apr; 103(8):1758-9; author reply 1760. PubMed ID: 15717298
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time for a worldwide shift from oral polio vaccine to inactivated polio vaccine.
    Shahzad A
    Clin Infect Dis; 2009 Oct; 49(8):1287-8. PubMed ID: 19780666
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of combined vaccines in children].
    Plebani A
    Ann Ig; 2002; 14(4 Suppl 5):85-91. PubMed ID: 12389297
    [No Abstract]   [Full Text] [Related]  

  • 8. Hunting for immune response regulatory genes: vaccination studies in infant twins.
    Newport MJ; Goetghebuer T; Marchant A
    Expert Rev Vaccines; 2005 Oct; 4(5):739-46. PubMed ID: 16221074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous vaccination in Japanese travelers.
    Mizuno Y; Kano S; Urashima M; Genka I; Kanagawa S; Kudo K
    Travel Med Infect Dis; 2007 Mar; 5(2):85-9. PubMed ID: 17298913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listen to mother first.
    Bawaskar HS
    Indian Pediatr; 2015 Mar; 52(3):257. PubMed ID: 25849016
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
    Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities and limits of vaccinations].
    Schneeweiss B
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):485-95. PubMed ID: 5114862
    [No Abstract]   [Full Text] [Related]  

  • 15. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
    Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommended childhood immunization schedule--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(2):35-40. PubMed ID: 9011782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination coverage of 2-year-old children--United States, 1992-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(15):282-3. PubMed ID: 8164635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommended childhood immunization schedule--United States, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Jan; 47(1):8-12. PubMed ID: 9450723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some aspects of immunity of vaccine in China].
    Wang K
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):245-6. PubMed ID: 10923473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.